C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Price:
41.51
CNY
0.24%
Market Closed
Market Cap:
110.9B
CNY
Income Statement
Earnings Waterfall
CSPC Innovation Pharmaceutical Co Ltd
CSPC Innovation Pharmaceutical Co Ltd
|
Revenue
|
2.1B
CNY
|
|
Cost of Revenue
|
-1.2B
CNY
|
|
Gross Profit
|
849.6m
CNY
|
|
Operating Expenses
|
-685.4m
CNY
|
|
Operating Income
|
164.1m
CNY
|
|
Other Expenses
|
147.3m
CNY
|
|
Net Income
|
311.4m
CNY
|
Income Statement
CSPC Innovation Pharmaceutical Co Ltd
CSPC Innovation Pharmaceutical Co Ltd
Currency: CNY
Millions
TTM
| Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||
| Revenue |
902
N/A
|
1 240
+38%
|
1 281
+3%
|
1 277
0%
|
1 299
+2%
|
1 257
-3%
|
1 270
+1%
|
1 290
+2%
|
1 329
+3%
|
1 317
-1%
|
1 319
+0%
|
1 338
+1%
|
1 333
0%
|
1 432
+7%
|
1 522
+6%
|
1 764
+16%
|
1 932
+10%
|
2 626
+36%
|
2 863
+9%
|
2 897
+1%
|
2 979
+3%
|
2 502
-16%
|
2 342
-6%
|
2 164
-8%
|
2 079
-4%
|
|
| Gross Profit | ||||||||||||||||||||||||||
| Cost of Revenue |
(467)
|
(631)
|
(668)
|
(652)
|
(654)
|
(612)
|
(630)
|
(608)
|
(611)
|
(584)
|
(579)
|
(640)
|
(672)
|
(746)
|
(833)
|
(972)
|
(1 058)
|
(1 492)
|
(1 659)
|
(1 679)
|
(1 722)
|
(1 368)
|
(1 309)
|
(1 237)
|
(1 229)
|
|
| Gross Profit |
435
N/A
|
609
+40%
|
613
+1%
|
625
+2%
|
644
+3%
|
645
+0%
|
640
-1%
|
682
+6%
|
718
+5%
|
733
+2%
|
740
+1%
|
698
-6%
|
661
-5%
|
686
+4%
|
689
+0%
|
792
+15%
|
874
+10%
|
1 135
+30%
|
1 204
+6%
|
1 218
+1%
|
1 257
+3%
|
1 134
-10%
|
1 033
-9%
|
926
-10%
|
850
-8%
|
|
| Operating Income | ||||||||||||||||||||||||||
| Operating Expenses |
(229)
|
(337)
|
(333)
|
(322)
|
(335)
|
(340)
|
(334)
|
(352)
|
(369)
|
(390)
|
(380)
|
(362)
|
(334)
|
(332)
|
(294)
|
(292)
|
(312)
|
(384)
|
(370)
|
(371)
|
(367)
|
(346)
|
(415)
|
(520)
|
(685)
|
|
| Selling, General & Administrative |
(234)
|
(329)
|
(334)
|
(340)
|
(341)
|
(334)
|
(340)
|
(352)
|
(369)
|
(380)
|
(385)
|
(354)
|
(325)
|
(317)
|
(283)
|
(281)
|
(295)
|
(328)
|
(324)
|
(321)
|
(317)
|
(296)
|
(286)
|
(259)
|
(233)
|
|
| Research & Development |
(8)
|
(11)
|
(12)
|
(12)
|
(13)
|
(13)
|
(13)
|
(13)
|
(12)
|
(14)
|
(14)
|
(16)
|
(18)
|
(18)
|
(24)
|
(23)
|
(30)
|
(44)
|
(54)
|
(58)
|
(59)
|
(44)
|
(143)
|
(276)
|
(470)
|
|
| Depreciation & Amortization |
0
|
(11)
|
0
|
0
|
0
|
(12)
|
0
|
0
|
0
|
(12)
|
0
|
0
|
0
|
(12)
|
0
|
0
|
0
|
(16)
|
0
|
0
|
0
|
(22)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
13
|
14
|
13
|
30
|
19
|
19
|
19
|
13
|
12
|
17
|
19
|
8
|
8
|
15
|
13
|
13
|
13
|
4
|
7
|
9
|
8
|
16
|
15
|
16
|
18
|
|
| Operating Income |
206
N/A
|
272
+32%
|
281
+3%
|
302
+8%
|
309
+2%
|
305
-2%
|
306
+1%
|
330
+8%
|
349
+6%
|
344
-2%
|
360
+5%
|
336
-7%
|
327
-3%
|
353
+8%
|
395
+12%
|
501
+27%
|
562
+12%
|
751
+34%
|
834
+11%
|
847
+2%
|
890
+5%
|
788
-11%
|
618
-22%
|
407
-34%
|
164
-60%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||
| Interest Income Expense |
7
|
5
|
4
|
8
|
20
|
28
|
44
|
45
|
27
|
16
|
14
|
13
|
23
|
38
|
38
|
56
|
86
|
105
|
97
|
112
|
94
|
104
|
115
|
85
|
66
|
|
| Non-Reccuring Items |
0
|
(0)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(0)
|
1
|
1
|
1
|
(1)
|
4
|
5
|
8
|
10
|
6
|
2
|
(2)
|
(1)
|
(1)
|
(11)
|
(10)
|
(11)
|
0
|
(0)
|
2
|
3
|
2
|
0
|
(3)
|
(4)
|
|
| Pre-Tax Income |
212
N/A
|
278
+31%
|
286
+3%
|
311
+9%
|
329
+6%
|
335
+2%
|
355
+6%
|
383
+8%
|
386
+1%
|
365
-5%
|
377
+3%
|
347
-8%
|
349
+1%
|
387
+11%
|
422
+9%
|
546
+30%
|
638
+17%
|
851
+33%
|
931
+9%
|
961
+3%
|
987
+3%
|
892
-10%
|
733
-18%
|
489
-33%
|
226
-54%
|
|
| Net Income | ||||||||||||||||||||||||||
| Tax Provision |
(41)
|
(53)
|
(55)
|
(60)
|
(62)
|
(62)
|
(65)
|
(68)
|
(69)
|
(66)
|
(67)
|
(64)
|
(62)
|
(71)
|
(78)
|
(90)
|
(103)
|
(125)
|
(133)
|
(136)
|
(140)
|
(136)
|
(130)
|
(106)
|
(100)
|
|
| Income from Continuing Operations |
171
|
224
|
231
|
252
|
267
|
274
|
290
|
316
|
317
|
300
|
310
|
283
|
287
|
317
|
344
|
456
|
535
|
727
|
798
|
825
|
847
|
755
|
603
|
383
|
125
|
|
| Income to Minority Interest |
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
49
|
109
|
186
|
|
| Net Income (Common) |
171
N/A
|
224
+31%
|
230
+3%
|
251
+9%
|
266
+6%
|
273
+3%
|
290
+6%
|
316
+9%
|
317
+0%
|
300
-5%
|
311
+4%
|
284
-9%
|
287
+1%
|
317
+10%
|
344
+9%
|
456
+32%
|
535
+17%
|
726
+36%
|
797
+10%
|
825
+3%
|
847
+3%
|
756
-11%
|
653
-14%
|
492
-25%
|
311
-37%
|
|
| EPS (Diluted) |
0.41
N/A
|
0.55
+34%
|
0.56
+2%
|
0.45
-20%
|
0.48
+7%
|
0.5
+4%
|
0.53
+6%
|
0.57
+8%
|
0.57
N/A
|
0.55
-4%
|
0.56
+2%
|
0.52
-7%
|
0.52
N/A
|
0.27
-48%
|
0.63
+133%
|
0.84
+33%
|
0.54
-36%
|
0.54
N/A
|
0.71
+31%
|
0.7
-1%
|
0.6
-14%
|
0.54
-10%
|
0.46
-15%
|
0.35
-24%
|
0.22
-37%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
